|
|
||||||||
Departments of Neurology (Drs. Vermeij and Hasan) and Neuroradiology (Dr. Tanghe), University Hospital Rotterdam Dijkzigt; the Department of Neurology (Dr. Vermeulen), Academisch Medisch Centrum, Amsterdam; and the University Department of Neurology (Dr. van Gijn), AZU, The Netherlands.
We studied the predictive factors for deterioration from hydrocephalus that developed during the first 28 days after admission in 660 patients following aneurysmal subarachnoid hemorrhage (SAH). Deterioration from hydrocephalus was defined as deterioration of consciousness with no detectable cause other than hydrocephalus confirmed by a repeat CT with a bicaudate index exceeding the 95th percentile for age. Deterioration from hydrocephalus occurred in 143 (22%) of the 660 patients. The variables included in the analysis were sex, age, loss of consciousness at ictus, sum score on the Glasgow Coma Scale on admission, sum score of cisternal blood and presence of ventricular blood on initial CT, hydrocephalus on initial CT, confirmed aneurysm, rebleeding, delayed cerebral ischemia, and treatment with tranexamic acid for 4 (short-term treatment) or 28 (long-term treatment) days. In a multivariate analysis with the Cox proportional hazards model incorporating fixed and time-dependent covariates, sum score of cisternal blood on initial CT (hazard ratio 3.15, p < 0.000001), presence of ventricular blood on initial CT (hazard ratio 1.66, p = 0.004), hydrocephalus on initial CT (hazard ratio 3.37, p < 0.000001), and long-term treatment with tranexamic acid (hazard ratio 2.40, p < 0.000001) were significantly related with the development of hydrocephalus. We conclude that a high amount of blood after SAH and delay of the resorption of cisternal and ventricular blood caused by long-term treatment with tranexamic acid increases the risk of deterioration from hydrocephalus after SAH.
Address correspondence and reprint requests to Dr. F.H. Vermeij, Department of Neurology, 40 Dr. Molewaterplein, 3015 GD Rotterdam, The Netherlands.
Received July 23, 1993. Accepted in final form March 23, 1994.
This article has been cited by other articles:
![]() |
C. A. Hellingman, W. M. van den Bergh, I. S. Beijer, G. W. van Dijk, A. Algra, J. van Gijn, and G. J.E. Rinkel Risk of Rebleeding After Treatment of Acute Hydrocephalus in Patients With Aneurysmal Subarachnoid Hemorrhage Stroke, January 1, 2007; 38(1): 96 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Pentney, S. C. Baraban, and W. F. Colmers NPY Sensitivity and Postsynaptic Properties of Heterotopic Neurons in the MAM Model of Malformation-Associated Epilepsy J Neurophysiol, November 1, 2002; 88(5): 2745 - 2754. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H Vermeij, D. Hasan, H. W. C. Bijvoet, and C. J. J. Avezaat Impact of Medical Treatment on the Outcome of Patients After Aneurysmal Subarachnoid Hemorrhage Stroke, May 1, 1998; 29(5): 924 - 930. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |